The	O
distal	B-ENHANCER
upstream	I-ENHANCER
region	I-ENHANCER
of	I-ENHANCER
insulin	I-ENHANCER
-	I-ENHANCER
like	I-ENHANCER
growth	I-ENHANCER
factor	I-ENHANCER
-	I-ENHANCER
binding	I-ENHANCER
protein	I-ENHANCER
-	I-ENHANCER
1	E-ENHANCER
enhances	O
its	O
expression	O
in	O
endometrial	O
stromal	O
cells	O
during	O
decidualization	O
.	O


We	O
have	O
previously	O
shown	O
that	O
decidualization	O
of	O
human	O
endometrial	O
stromal	O
cells	O
(	O
ESCs	O
)	O
causes	O
a	O
genome	O
-	O
wide	O
increase	O
in	O
the	O
levels	O
of	O
acetylation	O
of	O
histone	O
-	O
H3	O
Lys	O
-	O
27	O
(	O
H3K27ac	O
)	O
.	O


We	O
also	O
reported	O
that	O
the	O
distal	O
gene	O
regions	O
,	O
more	O
than	O
3	O
kb	O
up	O
-	O
or	O
downstream	O
of	O
gene	O
transcription	O
start	O
sites	O
have	O
increased	O
H3K27ac	O
levels	O
.	O


Insulin	O
-	O
like	O
growth	O
factor	O
-	O
binding	O
protein	O
-	O
1	O
(	O
IGFBP	O
-	O
1	O
)	O
is	O
a	O
specific	O
decidualization	O
marker	O
and	O
has	O
increased	O
H3K27ac	O
levels	O
in	O
its	O
distal	B-ENHANCER
upstream	I-ENHANCER
region	I-ENHANCER
(	I-ENHANCER
-	I-ENHANCER
4701	I-ENHANCER
to	I-ENHANCER
-	I-ENHANCER
7501	I-ENHANCER
bp	I-ENHANCER
)	E-ENHANCER
.	O


Here	O
,	O
using	O
a	O
luciferase	O
reporter	O
gene	O
construct	O
containing	O
this	O
IGFBP	B-ENHANCER
-	I-ENHANCER
1	I-ENHANCER
upstream	I-ENHANCER
region	E-ENHANCER
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
it	O
is	O
an	O
IGFBP	B-ENHANCER
-	I-ENHANCER
1	I-ENHANCER
enhancer	E-ENHANCER
.	O


To	O
induce	O
decidualization	O
,	O
we	O
incubated	O
ESCs	O
with	O
cAMP	O
and	O
found	O
that	O
cAMP	O
increased	O
luciferase	O
expression	O
,	O
indicating	O
that	O
decidualization	O
increased	O
the	O
transcriptional	O
activity	O
from	O
the	O
IGFBP	B-ENHANCER
-	I-ENHANCER
1	I-ENHANCER
upstream	I-ENHANCER
region	E-ENHANCER
.	O


Furthermore	O
,	O
CRISPR	O
/	O
Cas9	O
-	O
mediated	O
deletion	O
of	O
this	O
region	O
in	O
HepG2	O
cells	O
significantly	O
reduced	O
IGFBP	O
-	O
1	O
expression	O
,	O
confirming	O
its	O
role	O
as	O
an	O
IGFBP	B-ENHANCER
-	I-ENHANCER
1	I-ENHANCER
enhancer	E-ENHANCER
.	O


A	O
ChIP	O
assay	O
revealed	O
that	O
cAMP	O
increased	O
the	O
recruitment	O
of	O
the	O
transcriptional	O
regulators	O
CCAAT	O
enhancer	O
-	O
binding	O
protein	O
beta	O
(	O
C	O
/	O
EBPbeta	O
)	O
,	O
forkhead	O
box	O
O1	O
(	O
FOXO1	O
)	O
,	O
and	O
p300	O
to	O
the	O
IGFBP	B-ENHANCER
-	I-ENHANCER
1	I-ENHANCER
enhancer	E-ENHANCER
in	O
ESCs	O
.	O


Of	O
note	O
,	O
C	O
/	O
EBPbeta	O
knockdown	O
inhibited	O
the	O
stimulatory	O
effects	O
of	O
cAMP	O
on	O
the	O
levels	O
of	O
H3K27ac	O
,	O
chromatin	O
opening	O
,	O
and	O
p300	O
recruitment	O
at	O
the	O
IGFBP	B-ENHANCER
-	I-ENHANCER
1	I-ENHANCER
enhancer	E-ENHANCER
.	O


These	O
results	O
indicate	O
that	O
the	O
region	B-ENHANCER
-	I-ENHANCER
4701	I-ENHANCER
to	I-ENHANCER
-	I-ENHANCER
7501	I-ENHANCER
bp	I-ENHANCER
upstream	I-ENHANCER
of	I-ENHANCER
IGFBP	I-ENHANCER
-	I-ENHANCER
1	E-ENHANCER
functions	O
as	O
an	O
enhancer	B-ENHANCER
for	I-ENHANCER
IGFBP	I-ENHANCER
-	I-ENHANCER
1	E-ENHANCER
expression	O
in	O
ESCs	O
undergoing	O
decidualization	O
,	O
that	O
C	O
/	O
EBPbeta	O
and	O
FOXO1	O
bind	O
to	O
the	O
enhancer	B-ENHANCER
region	E-ENHANCER
to	O
up	O
-	O
regulate	O
IGFBP	O
-	O
1	O
expression	O
,	O
and	O
that	O
C	O
/	O
EBPbeta	O
induces	O
H3K27ac	O
by	O
recruiting	O
p300	O
to	O
the	O
IGFBP	B-ENHANCER
-	I-ENHANCER
1	I-ENHANCER
enhancer	E-ENHANCER
.	O
